Has Jennifer Messina received payments from drug or device companies?

Yes. Drug and device makers reported $10,107 in general payments to Jennifer Messina across 416 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jennifer Messina did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jennifer Messina come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jennifer Messina

Family · North Venice, FLNPI 1730734914

Payments from drug & device makers

$10,107in general payments, 2019–2025

Across 416 payments — averaging $24.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$705
Incyte Corporation$651
Daiichi Sankyo Inc.$649
AstraZeneca$643
Merck$558
Gilead$547
plus $6K from 53 others

What the payments were for

Food & beverage$8,75087%
Education$1,35713%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	26	$705
Incyte Corporation	21	$651
Daiichi Sankyo Inc.	24	$649
AstraZeneca(2 entities)	31	$643
Merck	21	$558
Gilead(2 entities)	17	$547
Pfizer	21	$517
E.r. Squibb & Sons, L.L.C.	28	$484
Seagen Inc.	8	$446
Novartis	25	$441
GSK	17	$411
Lilly USA, LLC	11	$247
Takeda Pharmaceuticals U.S.A., Inc.	9	$244
Ipsen Biopharmaceuticals, Inc	4	$244
Bristol Myers Squibb	8	$220
Beigene USA, Inc.	8	$202
Eisai Inc.	8	$187
Bayer	10	$181
AbbVie	8	$176
Sobi, Inc	8	$160
Exelixis Inc.	4	$158
Beone Medicines USA, Inc.	8	$131
Astellas Pharma US Inc	7	$130
Array Biopharma Inc	5	$113
Kyowa Kirin, Inc.	5	$109
Puma Biotechnology, Inc.	5	$98
Jazz Pharmaceuticals Inc.	3	$92
Amgen	4	$88
AVEO Pharmaceuticals, Inc.	4	$84
Agios Pharmaceuticals, Inc.	4	$77
Genmab U.S., Inc.	3	$74
Dendreon Pharmaceuticals LLC	3	$74
Sumitomo Pharma America, Inc.	4	$69
Genentech USA, Inc.	4	$67
Pharmacosmos Therapeutics Inc.	4	$65
Pharmacyclics LLC, An Abbvie Company	3	$65
Pharmaessentia USA Corporation	2	$62
Stemline Therapeutics Inc.	2	$53
Sanofi	3	$49
Boehringer Ingelheim	2	$45
Mirati Therapeutics, Inc.	2	$44
Blueprint Medicines Corporation	2	$39
Morphosys, US Inc.	2	$38
Epizyme, Inc.	2	$37
Tersera Therapeutics LLC	1	$32
Rigel Pharmaceuticals, Inc.	2	$30
Deciphera Pharmaceuticals Inc.	1	$25
Syndax Pharmaceuticals, Inc.	1	$25
Foundation Medicine, Inc.	1	$25
Legend Biotech USA Inc.	1	$25
Servier Pharmaceuticals LLC	1	$21
G1 Therapeutics, Inc.	1	$21
Recordati_rare_diseases_inc.	1	$20
Karyopharm Therapeutics Inc.	1	$20
EMD Serono, Inc.	1	$20
Iovance Biotherapeutics, Inc.	1	$19
ADC Therapeutics America, Inc.	1	$17
Taiho Oncology, Inc.	1	$17
Alnylam Pharmaceuticals Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OJJAARA$125

How this compares

$10,107 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dexamethasone	14	$306
Ondansetron OdtOndansetron	13	$292
Acyclovir	19	$135
Hydroxyurea	13	$120

Paid to pharmacies, not to this prescriber.

Other family in North Venice

John HuffakerVenice$8M
Stephanie MompointMiami$4.5M
Miguel TrujilloMiami Gardens$4.4M
Itsel Cardenas RamonMiami$1M
Lewis HarringtonTampa$954K
Adam StrosbergFort Lauderdale$859K
Danielle PharesFt Lauderdale$713K
David RodriguezHialeah$658K
Donna OrtizOrlando$417K
Patrick SzarazMiami$327K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →